Albumin for cirrhotic patients with extraperitoneal infections: A meta‐analysis
- 28 July 2019
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 34 (12) , 2071-2076
Abstract
Background and Aim: Bacterial infections are among the main causes of death in patients with cirrhosis. While there are unquestionable benefits of using albumin in patients with spontaneous bacterial peritonitis, the benefits of albumin are controversial for those with extraperitoneal infections. The aim was to compare the use of albumin associated to antibiotics and antibiotics alone in cirrhotic patients with extraperitoneal infections.Methods: A systematic review was performed using MEDLINE and Embase databases. Randomized controlled trials comparing albumin associated to antibiotics and antibiotics alone in cirrhotic patients with extraperitoneal infections were considered eligible, as long as at least one of the following outcomes was evaluated: mortality and renal dysfunction. Meta‐analysis was performed using the random effects model, through the Mantel–Haenszel method. The study protocol was registered at PROSPERO platform (CRD42018107191).Results: The literature search yielded 812 references. Three randomized controlled trials fulfilled the selection criteria and were included in this meta‐analysis. There was no evidence of significant difference between the groups regarding mortality in 30 days (risk ratio [RR] = 1.62, 95% confidence interval [CI]: 0.92–2.84, P = 0.09, I2 = 0%) or in 90 days (RR = 1.27, 95% CI: 0.89–1.83, P = 0.19, I2 = 0%). Regarding renal dysfunction, there was also no evidence of significant difference between the groups (RR = 0.55, 95% CI: 0.25–1.19, P = 0.13, I2 = 0%).Conclusion: There is no evidence of significant benefits of using albumin for cirrhotic patients with extraperitoneal infections regarding mortality or renal dysfunction.Keywords
This publication has 32 references indexed in Scilit:
- Albumin Reduces Paracentesis-Induced Circulatory Dysfunction and Reduces Death and Renal Impairment among Patients with Cirrhosis and Infection: A Systematic Review and Meta-AnalysisBioMed Research International, 2013
- Albumin infusion may deleteriously promote extracellular fluid overload without improving circulating hypovolemia in patients of advanced cirrhosis with diabetes mellitus and sepsisMedical Hypotheses, 2013
- Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled studyJournal of Hepatology, 2012
- Severe sepsis in cirrhosis†Hepatology, 2009
- Assessing Risk of Bias in Included Studies2008
- Renal Failure in Patients With Cirrhosis and Sepsis Unrelated to Spontaneous Bacterial Peritonitis: Value of MELD ScoreGastroenterology, 2005
- A Randomized Unblinded Pilot Study Comparing Albumin Versus Hydroxyethyl Starch in Spontaneous Bacterial Peritonitis * #Hepatology, 2005
- Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitisJournal of Hepatology, 2004
- Infecção bacteriana no paciente cirróticoArquivos de Gastroenterologia, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002